JAK2 and myeloproliferative neoplasm: Comparison of wildtype and JAK2-mutated MPN samples revealed a higher expression of pSTAT1 and IRF1 in JAK2-mutated cases with the highest levels in CD45+CD3+ T cells (Fig. 3L–N).